« Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrig’s Disease) – Genetic Engineering News (press release) | Home | Cytokinetics Announces Encouraging Results From Two Phase II Clinical Trials … – MarketWatch (press release) »
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig’s Disease – Xconomy
By | April 25, 2012
->
![]() Xconomy |
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig's Disease
Xconomy But South San Francisco-based Cytokinetics (NASDAQ: CYTK) is reporting today on clinical trial results that offer a hint it could be onto something for treating amyotrophic lateral sclerosis (ALS). An experimental drug from Cytokinetics met its main … |
Topics: Uncategorized | No Comments »

